In the Zinzino Revenue Q1 2025 shows exceptional growth, with the Scandinavian wellness giant reporting a 59% year-over-year revenue increase. For the first quarter ending March 31, 2025, total revenue reached SEK 723.7 million, up from SEK 454.5 million in Q1 2024.
In local currencies, the growth rate was even higher—60%—marking a robust performance across global markets.
“This quarter demonstrates our aggressive international expansion and successful integration of key acquisitions,” said the company.
EBITDA: SEK 78.8M, up from SEK 51.7M
The company’s EBITDA margin remained steady despite market expansion costs, showing resilience and operational efficiency.
During Q1, Zinzino completed the acquisition of Zurvita’s assets, including its distributor and customer databases. This move strengthens Zinzino’s footprint in North America.
In parallel, the company launched operations in New Zealand, adding another strategic market to its global reach. Post-quarter, Zinzino also finalized the acquisition of Valentus Global’s assets—expanding its distribution network across Europe.
Is Zinzino’s Board proposed a dividend of SEK 4.00 per share for the 2024 financial year, up from SEK 3.00. The total payout is projected at SEK 143.1 million, reflecting the company’s confidence in sustainable growth and cash flow generation.
The Zinzino is a global leader in test-based, personalized nutrition and skincare. Listed on Nasdaq First North Premier Growth Market, the company operates in over 100 markets. Zinzino owns BioActive Foods AS and Faun Pharma AS and co-owns Cleanthi Alpha-Olenic LTD.
Its acquisition portfolio includes Zurvita, Xelliss, Valentus Global, and HANZZ+HEIDII, positioning it as a powerhouse in both wellness and beauty.
Find out more
Zinzino Expands Globally, Launches in New Zealand
Top Leader Beth BrannanJoins Global Wellness Brand Zinzino
Zinzino Acquires Valentus Global to Strengthen Wellness Business
There are no reviews yet. Be the first one to write one.
